TrialJournal of the American Heart Association2015

CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study.

Caitrin W McDonough et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.